| Preventing an antigenically disruptive mutation in egg-based H3N2 seasonal influenza vaccines by mutational incompatibility NC Wu, H Lv, AJ Thompson, DC Wu, WWS Ng, RU Kadam, CW Lin, ... Cell host & microbe 25 (6), 836-844. e5, 2019 | 75 | 2019 |
| T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study CKP Mok, A Zhu, J Zhao, EHY Lau, J Wang, Z Chen, Z Zhuang, Y Wang, ... The Lancet Infectious Diseases 21 (3), 385-395, 2021 | 62 | 2021 |
| Serum cytokine profiles in patients with dengue fever at the acute infection phase J Huang, W Liang, S Chen, Y Zhu, H Chen, CKP Mok, Y Zhou Disease markers 2018 (1), 8403937, 2018 | 42 | 2018 |
| Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential Z Zhou, KPY Hui, RTY So, H Lv, RAPM Perera, DKW Chu, E Gelaye, ... Proceedings of the National Academy of Sciences 118 (25), e2103984118, 2021 | 31 | 2021 |
| Clinical features, replication competence, and innate immune responses of human adenovirus type 7 infection Q Chen, J Liu, W Liang, Y Chen, M Dou, Z Liu, Y Chen, Z Zheng, B Zhu, ... The Journal of Infectious Diseases 223 (8), 1390-1399, 2021 | 26 | 2021 |
| Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase R Lei, W Kim, H Lv, Z Mou, MJ Scherm, AJ Schmitz, JS Turner, TJC Tan, ... Immunity 56 (11), 2621-2634. e6, 2023 | 18 | 2023 |
| Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution W Liang, TJC Tan, Y Wang, H Lv, Y Sun, R Bruzzone, CKP Mok, NC Wu PLoS pathogens 18 (9), e1010875, 2022 | 14 | 2022 |
| Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice H Lv, OTY Tsang, RTY So, Y Wang, M Yuan, H Liu, GK Yip, QW Teo, Y Lin, ... European Journal of Immunology 51 (9), 2296-2305, 2021 | 7 | 2021 |
| Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin R Lei, W Liang, WO Ouyang, A Hernandez Garcia, C Kikuchi, S Wang, ... Nature Communications 15 (1), 5175, 2024 | 5 | 2024 |
| Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations J Lou, W Liang, L Cao, I Hu, S Zhao, Z Chen, RWY Chan, PPH Cheung, ... Nature communications 15 (1), 2546, 2024 | 4 | 2024 |
| Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season–a serological study using retrospective samples collected in Hong Kong W Liang, H Lv, C Chen, Y Sun, DS Hui, CKP Mok International Journal of Infectious Diseases 135, 1-4, 2023 | 3 | 2023 |
| Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China Y Luo, H Lv, S Zhao, Y Sun, C Liu, C Chen, W Liang, K Kwok, QW Teo, ... International Journal of Infectious Diseases 127, 26-32, 2023 | 3 | 2023 |
| Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model H Lv, QW Teo, CCD Lee, W Liang, D Choi, KJ Mao, MR Ardagh, AB Gopal, ... Journal of Virology, e01695-24, 2024 | | 2024 |
Chris Ka Pun MokThe Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong在 cuhk.edu.hk 的电子邮件经过验证
